Inventiva S.A.

Paris Stock Exchange IVA.PA

Inventiva S.A. Debt to Equity Ratio for the year ending December 31, 2023: -1.17

Inventiva S.A. Debt to Equity Ratio is -1.17 for the year ending December 31, 2023, a -254.21% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Inventiva S.A. Debt to Equity Ratio for the year ending December 31, 2022 was 0.76, a 566.52% change year over year.
Inventiva S.A. Debt to Equity Ratio for the year ending December 31, 2021 was 0.11, a -4.46% change year over year.
Inventiva S.A. Debt to Equity Ratio for the year ending December 31, 2020 was 0.12, a 134.68% change year over year.
Inventiva S.A. Debt to Equity Ratio for the year ending December 31, 2019 was 0.05, a 41.99% change year over year.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

Paris Stock Exchange: IVA.PA

Inventiva S.A.

CEO	Mr. Frederic Cren
IPO Date	Feb. 15, 2017
Location	France
Headquarters	50 rue de Dijon
Employees	123
Sector	Health Care
Industries Pharmaceuticals Biotechnology Clinical Trials

Description

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France.

Key trends

Past 5 years